HCA Healthcare (HCA)
(Delayed Data from NYSE)
$405.11 USD
+3.31 (0.82%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $405.12 +0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth F Momentum A VGM
Average Brokerage Rating
Current ABR | 1.43 |
ABR (Last week) | 1.43 |
# of Recs in ABR | 23 |
Average Target Price | $393.77 |
LT Growth Rate | 11.90% |
Industry | Medical - Hospital |
Industry Rank by ABR | 3 of 253 |
Current Quarter EPS Est: | 4.93 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 17 | 17 | 16 | 16 | 16 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.43 | 1.43 | 1.45 | 1.45 | 1.45 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/3/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/29/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
8/23/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
8/14/2024 | UBS | Aj Rice | Strong Buy | Strong Buy |
8/2/2024 | Argus Research Corp. | David A Toung | Strong Buy | Strong Buy |
8/1/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/30/2024 | Wells Fargo Securities | Stephen Baxter | Hold | Hold |
7/24/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
7/24/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
7/24/2024 | SVB Securities | Whit Mayo | Strong Buy | Strong Buy |
7/24/2024 | Raymond James | John W Ransom | Moderate Buy | Moderate Buy |
7/11/2024 | Cowen & Co. | Ryan Langston | Not Available | Strong Buy |
7/10/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/2/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Buy | Strong Buy |
5/30/2024 | Robert W. Baird & Co. | Michael Ha | Not Available | Strong Buy |
5/14/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
5/1/2024 | Stephens | Scott Fidel | Strong Buy | Strong Buy |
4/29/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
3/4/2024 | Goldman Sachs | Jamie Perse | Hold | Hold |
1/4/2024 | Not Identified | Not Identified | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.